ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates

MHRA Drug Safety Updates

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

Drug Safety Update MHRA April 2019 PDF final.pdf

Drug Safety Update MHRA April 2019 PDF final.pdf
Summary: Yellow, fever, stamaril, valproate, belimumab, benlysta, lyrica, pregabalin, gabapentin, elvitegravir
File Size: 304KB
File Type: application/pdf
Created: 25 April 2019
Last Modified: 22 May 2019